Mandate

Vinge has advised Bilia AB publ

December 05, 2016

Vinge has advised Bilia AB (publ), listed on NASDAQ Stockholm, in conjunction with a tap issue of MSEK 250 within the scope of its non-subordinated corporate bonds, with a maturity date in March 2021.

The issue was performed as an interest expense corresponding to STIBOR 3 months + 150 interest points up to maturity. In total, the new outstanding amount following the issue is MSEK 750.

Vinge’s team consisted of responsible advokat Yohanna Öhrnegård assisted by Lina André.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025